相似文献
1
Integrated Genomics for Pinpointing Survival Loci within Arm-Level Somatic Copy Number Alterations.
Cancer Cell. 2016 May 9;29(5):737-750. doi: 10.1016/j.ccell.2016.03.025.
2
Breast and prostate cancers harbor common somatic copy number alterations that consistently differ by race and are associated with survival.
BMC Med Genomics. 2020 Aug 20;13(1):116. doi: 10.1186/s12920-020-00765-2.
3
Genomic and epigenetic aberrations of chromosome 1p36.13 have prognostic implications in malignancies.
Chromosome Res. 2020 Dec;28(3-4):307-330. doi: 10.1007/s10577-020-09638-x. Epub 2020 Aug 20.
4
Identification of Gene Expression Pattern Related to Breast Cancer Survival Using Integrated TCGA Datasets and Genomic Tools.
Biomed Res Int. 2015;2015:878546. doi: 10.1155/2015/878546. Epub 2015 Oct 20.
5
Molecular analysis of urothelial cancer cell lines for modeling tumor biology and drug response.
Oncogene. 2017 Jan 5;36(1):35-46. doi: 10.1038/onc.2016.172. Epub 2016 Jun 6.
6
Identification of driver copy number alterations in diverse cancer types and application in drug repositioning.
Mol Oncol. 2017 Oct;11(10):1459-1474. doi: 10.1002/1878-0261.12112. Epub 2017 Aug 3.
7
Somatic Copy Number Alterations at Oncogenic Loci Show Diverse Correlations with Gene Expression.
Sci Rep. 2016 Jan 20;6:19649. doi: 10.1038/srep19649.
8
Identification of candidate cancer drivers by integrative Epi-DNA and Gene Expression (iEDGE) data analysis.
Sci Rep. 2019 Nov 15;9(1):16904. doi: 10.1038/s41598-019-52886-z.
9
Comprehensive Characterization of Molecular Differences in Cancer between Male and Female Patients.
Cancer Cell. 2016 May 9;29(5):711-722. doi: 10.1016/j.ccell.2016.04.001.
10
An integrative analysis of the age-associated multi-omic landscape across cancers.
Nat Commun. 2021 Apr 20;12(1):2345. doi: 10.1038/s41467-021-22560-y.
引用本文的文献
1
Assessment of CDKN2A homozygous and heterozygous deletions in gliomas across multiple detection platforms.
BMC Cancer. 2025 Jun 5;25(1):1007. doi: 10.1186/s12885-025-14266-x.
2
Rapid diagnosis of adult-type diffuse glioma using a layered scheme.
BMC Med. 2025 Jun 2;23(1):325. doi: 10.1186/s12916-025-04124-9.
3
Frequency and Prognostic Impact of CDKN2A/B Alteration in Oligodendrogliomas: Systematic Review and Meta-analysis.
Neurol Med Chir (Tokyo). 2024 Dec 15;64(12):442-450. doi: 10.2176/jns-nmc.2024-0105. Epub 2024 Oct 22.
4
Hemizygous deletion of cyclin-dependent kinase inhibitor 2A/B with p16 immuno-negative and methylthioadenosine phosphorylase retention predicts poor prognosis in IDH-mutant adult glioma.
Neurooncol Adv. 2024 May 8;6(1):vdae069. doi: 10.1093/noajnl/vdae069. eCollection 2024 Jan-Dec.
5
FASTKD1 as a diagnostic and prognostic biomarker for STAD: Insights into m6A modification and immune infiltration.
Exp Ther Med. 2024 May 31;28(2):305. doi: 10.3892/etm.2024.12594. eCollection 2024 Aug.
6
Exploring the prognostic significance of arm-level copy number alterations in triple-negative breast cancer.
Oncogene. 2024 Jun;43(26):2015-2024. doi: 10.1038/s41388-024-03051-y. Epub 2024 May 14.
7
Measuring cancer driving force of chromosomal aberrations through multi-layer Boolean implication networks.
PLoS One. 2024 Apr 9;19(4):e0301591. doi: 10.1371/journal.pone.0301591. eCollection 2024.
8
Chromosome 8p engineering reveals increased metastatic potential targetable by patient-specific synthetic lethality in liver cancer.
Sci Adv. 2023 Dec 22;9(51):eadh1442. doi: 10.1126/sciadv.adh1442.
9
Development and evaluation of a risk score model based on a WNT score gene-associated signature for predicting the clinical outcome and the tumour microenvironment of hepatocellular carcinoma.
Int J Immunopathol Pharmacol. 2023 Jan-Dec;37:3946320231218179. doi: 10.1177/03946320231218179.
10
Tracing cancer evolution and heterogeneity using Hi-C.
Nat Commun. 2023 Nov 6;14(1):7111. doi: 10.1038/s41467-023-42651-2.
本文引用的文献
1
Glioma Groups Based on 1p/19q, IDH, and TERT Promoter Mutations in Tumors.
N Engl J Med. 2015 Jun 25;372(26):2499-508. doi: 10.1056/NEJMoa1407279. Epub 2015 Jun 10.
2
Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas.
N Engl J Med. 2015 Jun 25;372(26):2481-98. doi: 10.1056/NEJMoa1402121. Epub 2015 Jun 10.
3
Pan-cancer network analysis identifies combinations of rare somatic mutations across pathways and protein complexes.
Nat Genet. 2015 Feb;47(2):106-14. doi: 10.1038/ng.3168. Epub 2014 Dec 15.
4
Identification of causal genetic drivers of human disease through systems-level analysis of regulatory networks.
Cell. 2014 Oct 9;159(2):402-14. doi: 10.1016/j.cell.2014.09.021.
5
Multiplatform analysis of 12 cancer types reveals molecular classification within and across tissues of origin.
Cell. 2014 Aug 14;158(4):929-944. doi: 10.1016/j.cell.2014.06.049. Epub 2014 Aug 7.
6
Multi-tiered genomic analysis of head and neck cancer ties TP53 mutation to 3p loss.
Nat Genet. 2014 Sep;46(9):939-43. doi: 10.1038/ng.3051. Epub 2014 Aug 3.
7
Molecular genetics of gliomas.
Cancer J. 2014 Jan-Feb;20(1):66-72. doi: 10.1097/PPO.0000000000000020.
8
ChAMP: 450k Chip Analysis Methylation Pipeline.
Bioinformatics. 2014 Feb 1;30(3):428-30. doi: 10.1093/bioinformatics/btt684. Epub 2013 Dec 12.
9
Cumulative haploinsufficiency and triplosensitivity drive aneuploidy patterns and shape the cancer genome.
Cell. 2013 Nov 7;155(4):948-62. doi: 10.1016/j.cell.2013.10.011. Epub 2013 Oct 31.
10
Pan-cancer patterns of somatic copy number alteration.
Nat Genet. 2013 Oct;45(10):1134-40. doi: 10.1038/ng.2760.
Zotero 插件